People: Covidien PLC (COV)

COV on New York Consolidated

65.17USD
24 May 2013
Price Change (% chg)

$-0.04 (-0.06%)
Prev Close
$65.21
Open
$64.99
Day's High
$65.62
Day's Low
$64.57
Volume
1,800,414
Avg. Vol
2,530,273
52-wk High
$68.83
52-wk Low
$50.25

Search Stocks

Summary

Name Age Since Current Position

Jose Almeida

 50 2012 Chairman of the Board, President, Chief Executive Officer

Charles Dockendorff

 58 2007 Chief Financial Officer, Executive Vice President

John Masterson

 51 2007 Senior Vice President, General Counsel

Michael Dunford

 52 2009 Senior Vice President - Human Resources

James Clemmer

 48 2009 Senior Vice President and President - Medical Supplies Business

Bryan Hanson

 45 2011 Senior Vice President and Group President - Surgical Solutions

Amy McBride-Wendell

 51 2006 Senior Vice President - Strategy and Business Development

Michael Sgrignari

 49 2011 Senior Vice President - Quality and Operations

Jacqueline Strayer

 58 2013 Senior Vice President - Corporate Communications

Mark Trudeau

 51 2012 Senior Vice President, President - Pharmaceuticals

Peter Wehrly

 53 2011 Senior Vice President and Group President - Respiratory & Monitoring Solutions and Vascular Therapies

Richard Brown

 64 2006 Vice President, Chief Accounting Officer, Corporate Controller

Coleman Lannum

 48 Vice President - Investor Relations

Eric Green

 54 2007 Vice President, Chief Tax Officer

Dennis Reilley

 59 2013 Lead Independent Director

Joy Amundson

 58 2012 Independent Director

Craig Arnold

 52 2007 Independent Director

Robert Brust

 69 2007 Independent Director

John Connors

 70 2007 Independent Director

Christopher Coughlin

 60 2007 Independent Director

Randall Hogan

 57 2007 Independent Director

Martin Madaus

 53 2011 Independent Director

Joseph Zaccagnino

 66 2007 Independent Director
» Insider Trading

Biographies

Name Description

Jose Almeida

 Mr. Jose E. Almeida is Chairman of the Board, President, Chief Executive Officer of Covidien Plc. He has served as the Chairman of Company's Board of Directors since March of 2012. He has served on Company's Board of Directors since becoming Covidien’s President and Chief Executive Officer in July 2011. Prior to assuming the role of President and Chief Executive Officer of Covidien, Mr. Almeida served, from October 2006 to June 2011, as the President of Company's Medical Devices business segment. Prior to that, from April 2004 to September 2006, Mr. Almeida was President of Covidien’s International business. From January 2003 to April 2004, Mr. Almeida was Chief Operating Officer of Greatbatch, Inc., a developer and manufacturer of power sources and components for implantable medical devices. Mr. Almeida joined the Company in 1995 as Director of Corporate Engineering and then held several positions of increasing responsibility, including Vice President of European Manufacturing and Vice President of Global Manufacturing, through December 2002.

Charles Dockendorff

 Mr. Charles J. Dockendorff is Chief Financial Officer, Executive Vice President of Covidien Plc. Prior to that, from October 1995 to November 2006, Mr. Dockendorff served as Vice President and Chief Financial Officer of Covidien.

John Masterson

 Mr. John H. Masterson is Senior Vice President, General Counsel of Covidien Plc. Prior to that, from April 1999 to November 2006, Mr. Masterson served as Vice President and General Counsel of Covidien.

Michael Dunford

 Mr. Michael P. Dunford is Senior Vice President - Human Resources of Covidien Plc., since July 2009. Prior to that, Mr. Dunford served as Vice President, Human Resources Global Processes and Systems of Covidien since May 2008. Mr. Dunford served as Vice President, Human Resources, Operations of Covidien from December 2006 to May 2008, and served as Vice President, Corporate Human Resources of Covidien from May 2003 to December 2006. Mr. Dunford held several other human resources positions with Covidien since September 1999.

James Clemmer

 Mr. James C. Clemmer is Senior Vice President and President - Medical Supplies Business of Covidien Plc. Mr. Clemmer has been Senior Vice President of Covidien since November 2009. Mr. Clemmer has been President of Covidien’s Medical Supplies business segment since October 2006. From June 2004 to September 2006, Mr. Clemmer was Group President of the Kendall Healthcare division of Covidien, from June 2001 to June 2004, Mr. Clemmer was President of the SharpSafety and Critical Care divisions of Covidien and, from March 2001 to June 2001, Mr. Clemmer was Vice President and General Manager of the SharpSafety division of Covidien.

Bryan Hanson

 Mr. Bryan C. Hanson is Senior Vice President and Group President - Surgical Solutions of Covidien Plc., since July 2011. Prior to that, from July 2006 to June 2011, Mr. Hanson served as President of Covidien’s Energy-based Devices business. Mr. Hanson held several other positions of increasing responsibility in sales, marketing and general management with Covidien since October 1992.

Amy McBride-Wendell

 Ms. Amy A. McBride-Wendell is Senior Vice President - Strategy and Business Development of Covidien Plc., since December 2006. Prior to that, from March 1998 to November 2006, Ms. McBride-Wendell served as Vice President, Business Development of Covidien.

Michael Sgrignari

 Mr. Michael Sgrignari is Senior Vice President - Quality and Operations of Covidien Plc., since July 2011. Prior to that, from May 2008 to June 2011, Mr. Sgrignari was Vice President, Operations, of Covidien’s Medical Devices business segment. Mr. Sgrignari held several other positions of increasing responsibility in engineering and operations positions with Covidien since January 1991.

Jacqueline Strayer

 Ms. Jacqueline F. Strayer is Senior Vice President - Corporate Communications of Covidien Plc. In this role, Strayer will be responsible for Covidien's global communications strategies. This encompasses both internal and external communications initiatives worldwide, including corporate marketing, public relations, media relations, financial communications, crisis communications, issues management, philanthropy and the company's digital presence. She joins Covidien from Johnson Controls where she served as Vice President, Corporate Communications and was an elected officer of the company. Her responsibilities included media relations, internal communications, branding, advertising, digital and social media for this global industrial company. Before joining Johnson Controls, Strayer was Vice President, Corporate Communications for Arrow Electronics, Inc., where she established the communications function for this Fortune 200 company. Prior to that, she held communication leadership positions at United Technologies, GE Capital Corporation and William M. Mercer. Throughout her career, she has been recognized for her role in developing communications and public affairs programs. Active in the community, Strayer has served on the board of numerous organizations including Milwaukee Film, where she co-chaired the Film Industry committee, the Milwaukee Symphony Orchestra, WLIW/WNET, and she chaired Connecticut Public Broadcasting. She is a member of the Arthur Page Society, The Seminar and the Communication Strategy Council of the Conference Board. She received a Bachelor of Arts in political science and economics from the University of Connecticut and a Master of Professional Studies from New York University, Tisch School of the Arts, Graduate Division of Film and Television.

Mark Trudeau

 Mr. Mark C. Trudeau serves as Senior Vice President, President - Pharmaceuticals of Covidien Plc. Prior to joining Bayer, Trudeau served as senior vice president and general manager of the Bristol-Myers Squibb Immunology Division. Previous positions at Bristol-Myers Squibb included posts in marketing and assignments the company's regional operations. These posts included regional president, Asia-Pacific, based in Singapore; president, Canadian Operations, headquartered in Montreal; and managing director and general manager, United Kingdom Operations, based in London. After earning a Bachelor of Science degree in chemical engineering from the University of Michigan, Trudeau began his career at Eli Lilly & Co., followed by positions of increasing responsibility at E. I. du Pont de Nemours and Company and Abbott Laboratories. He holds an MBA degree from the University of Michigan. Mr. Trudeau currently serves on the Board of Directors of the Pharmaceutical Research and Manufacturers of America and the Board of Trustees of HealthCare Institute of New Jersey. He also served on the Board of Directors of the National Pharmaceutical Council from 2008-2010.

Peter Wehrly

 Mr. Peter L. Wehrly is Senior Vice President and Group President - Respiratory & Monitoring Solutions and Vascular Therapies of Covidien Plc., since July 2011. Prior to that, from April 2009 to June 2011, Mr. Wehrly served as President of Covidien’s Respiratory & Monitoring Solutions business. Prior to joining Covidien, Mr. Wehrly was President and Chief Executive Officer of Medingo Ltd., a company that produces miniature insulin patch pumps.

Richard Brown

 Mr. Richard G. Brown, Jr., is Vice President, Chief Accounting Officer, Corporate Controller of Covidien Plc., since September 2006. Prior to joining Covidien, he was Corporate Controller and Chief Accounting Officer of Eastman Kodak Company from December 2003 to September 2006. Prior to joining Eastman Kodak, Mr. Brown was a partner at Ernst & Young LLP, where he was employed for 32 years.

Coleman Lannum

 Mr. Coleman N. Lannum is Vice President - Investor Relations of Covidien Plc., since September 2006. He was retired from November 2005 until he joined Covidien. From February 2005 to November 2005, Mr. Lannum was a vice president for American Express Asset Management. Prior to that, Mr. Lannum was a vice president and portfolio manager with Putnam Investments.

Eric Green

 Mr. Eric C. Green is Vice President, Chief Tax Officer of Covidien Plc. Prior to that, from October 2003 to June 2007, he was Vice President, Tax Planning and Analysis of Tyco International. Prior to joining Tyco International, Mr. Green was with Accenture where he was Director, Entity Tax Matters Group from July 2001 to September 2003 and Director, Global Tax Strategy/Planning from February 1998 to July 2001.

Dennis Reilley

 Mr. Dennis H. Reilley has been appointed as Lead Independent Director of Covidien Plc. He joined company's Board of Directors in June 2007 in connection with company's establishment as a stand-alone public company and served as the Chairman of Company's Board of Directors until October 2008. From 2000 to April 2007, Mr. Reilley served as Chairman of Praxair, Inc., a supplier of industrial gases and high-performance surface coatings, and also served as Chief Executive Officer of Praxair from 2000 to December 2006. Prior to joining Praxair, Mr. Reilley held many key positions at E. I. du Pont de Nemours and Company from 1989 to 1999 when he was named Chief Operating Officer. Earlier in his career he held various managerial positions at Conoco. Mr. Reilley is currently a director of H.J. Heinz Company, Marathon Oil Corporation and The Dow Chemical Company.

Joy Amundson

 Ms. Joy A. Amundson is Independent Director of Covidien Plc., since June 14, 2012. Ms. Amundson is a principal of Amundson Partners, Inc., a healthcare consulting firm. From August 2004 to October 2010, Ms. Amundson was the President of Baxter BioScience Corporation and Vice President of Baxter International, Inc. Prior to Baxter, she was with Amundson Partners for three years. Prior to joining Amundson Partners, she was with Abbott Laboratories for over 20 years, where she held several key positions, including Senior Vice President. Ms. Amundson began her business career in sales and brand management with Procter & Gamble, a packaged goods company, from 1977 to 1982. Ms. Amundson previously served as a director of ApaTech, Dial Corporation, Ilex Oncology, Inc., Inamed Corporation and Oridion Medical Ltd.

Craig Arnold

 Mr. Craig Arnold is Independent Director of Covidien Plc. He joined the company's Board of Directors in June 2007 in connection with company's establishment as a stand-alone public company. Mr. Arnold is the Vice Chairman and Chief Operating Officer, Industrial Sector of Eaton Corporation, a diversified industrial manufacturer. From 2000 to 2008 he served as Senior Vice President of Eaton Corporation and President of the Fluid Power Group of Eaton. Prior to joining Eaton, Mr. Arnold was employed in a series of progressively more responsible positions at General Electric Company from 1983 to 2000. Mr. Arnold previously served as a director of Unocal Corporation, where he also was a member of the Audit Committee.

Robert Brust

 Mr. Robert H. Brust is Independent Director of Covidien Plc. Mr. Brust joined Company's Board of Directors in June 2007 in connection with Company's establishment as a stand-alone public company. Mr. Brust served as the Chief Financial Officer of Sprint Nextel Corporation, a wireless and wireline communications company, from May 2008 until his retirement in April 2011. From February 2007 to May 2008, Mr. Brust was retired. From January 2000 to February 2007, Mr. Brust served as Executive Vice President of Eastman Kodak Company, a provider of photographic products and services, and, from January 2000 to November 2006, he also served as Chief Financial Officer of Kodak. Prior to joining Kodak, Mr. Brust was Senior Vice President and Chief Financial Officer of Unisys Corporation from 1997 to 1999. He also worked in a variety of financial and financial management positions at General Electric Company from 1965 to 1997. Mr. Brust is currently a director of Smith & Wesson Holding Corporation and previously served as a director of Delphi Corporation and Applied Materials, Inc.

John Connors

 Mr. John M. Connors, Jr. is no longer Independent Director of Covidien Plc effective September 27, 2013. He joined Company's Board of Directors in June 2007 in connection with Company's establishment as a stand-alone public company. Since 2006, Mr. Connors has served as Chairman Emeritus of Hill, Holliday (formerly Hill, Holliday, Connors, Cosmopulos, Inc), a full-service advertising agency that is part of The Interpublic Group of Companies, Inc. From 2003 to 2006, Mr. Connors served as Chairman of Hill, Holliday, and from 1968 to 2003 he was Chairman, President and Chief Executive Officer of Hill, Holliday. Mr. Connors is currently a director of Hasbro, Inc and serves on Hasbro’s Compensation Committee, Executive Committee and Nominating, Governance and Social Responsibility Committee.

Christopher Coughlin

 Mr. Christopher J. Coughlin is Independent Director of Covidien Plc. He joined Company's Board of Directors in June 2007 in connection with Company's establishment as a stand-alone public company. Mr. Coughlin served as an advisor to Tyco International, a global provider of security products and services, fire protection and detection products and services, valves and controls, and other industrial products from December 2010 to September 2012. From March 2005 to December 2010, Mr. Coughlin served as Executive Vice President and Chief Financial Officer of Tyco International. Prior to joining Tyco International, Mr. Coughlin served as Chief Operating Officer of The Interpublic Group of Companies, Inc. from June 2003 to December 2004. He joined Interpublic from Pharmacia Corporation, where he was Chief Financial Officer from 1998 to 2003. Previously, he held the position of Executive Vice President and Chief Financial Officer of Nabisco Holdings, where he also served as President of Nabisco International. Mr. Coughlin is currently the Lead Director of The Dun & Bradstreet Corporation board and a director of Forest Laboratories, Inc. He previously served as a director of Perrigo Company, Monsanto Company and Interpublic.

Randall Hogan

 Mr. Randall J. Hogan III is Independent Director of Covidien Plc. Mr. Hogan joined Company's Board of Directors in June 2007 in connection with Company's establishment as a stand-alone public company. Mr. Hogan has served as Chief Executive Officer of Pentair, Inc., an industrial manufacturing company, since 2001 and was appointed Chairman in 2002. From 1999 to 2000, he was President and Chief Operating Officer and from 1998 to 1999, he was Executive Vice President and President of Pentair’s Electrical and Electronic Enclosures Group. Prior to joining Pentair, he was President of United Technologies’ Carrier Transicold Division. Before that, he was with the Pratt & Whitney division of United Technologies, General Electric Company and McKinsey & Company. Mr. Hogan previously served as a director of Unisys Corporation.

Martin Madaus

 Dr. Martin D. Madaus, Ph.D., is Independent Director of Covidien Plc. He joined company's Board of Directors in December 2011. Dr. Madaus is the Executive Chairman of Quanterix Corporation, a privately-held development stage diagnostics company seeking to develop and commercialize blood tests that measure clinically important proteins in blood. Prior to joining Quanterix, Dr. Madaus was the President and Chief Executive Officer of Millipore Corporation, a life sciences company serving the bioscience research and biopharmaceutical manufacturing industry, from January 2005 to July 2010, and Chairman from March 2005 to July 2010, when Millipore was acquired by Merck KGaA. Prior to joining Millipore, he was at Roche Diagnostics Corporation where, as President and Chief Executive Officer, he was responsible for the North American operations. Dr. Madaus is currently a director of Mettler-Toledo International, where he serves on the Audit Committee. Dr. Madaus is also a director of PPD Inc, a privately-held clinical research organization.

Joseph Zaccagnino

 Mr. Joseph A. Zaccagnino is Independent Director of Covidien Plc. He joined Company's Board of Directors in June 2007 in connection with Company's establishment as a stand-alone public company. Mr. Zaccagnino, who has held leadership positions in the healthcare sector for over 40 years, served as President, Chief Executive Officer and Director of Yale New Haven Health System and its flagship Yale-New Haven Hospital, the primary teaching and research affiliate of the Yale University School of Medicine, from 1991 until his retirement in 2005. Yale New Haven Health System facilities include free-standing: acute care adult and children’s hospitals; psychiatric and cancer hospitals; rehabilitation services; ambulatory surgery, outpatient diagnostic imaging, primary care and emergency centers; and health insurance products. Mr. Zaccagnino previously served as a director of NewAlliance Bancshares, Inc.

Insider Trading

» Full list on Insider Trading
Search Stocks